{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T17:14:12Z","timestamp":1778519652211,"version":"3.51.4"},"reference-count":60,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,5,11]]},"DOI":"10.7759\/cureus.108667","type":"journal-article","created":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T17:05:15Z","timestamp":1778519115000},"source":"Crossref","is-referenced-by-count":0,"title":["Ceramides and Type 2 Diabetes: A Scoping Review of Mechanisms, Insulin Resistance, and Nutritional Interventions"],"prefix":"10.7759","author":[{"given":"Karin","family":"Collins","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jyotsna","family":"Chawla","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Priya","family":"Krishnakumar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1126\/science.aax6594","article-title":"Lowering ceramides to overcome diabetes","volume":"365","author":"Kusminski CM","year":"2019","unstructured":"Kusminski CM, Scherer PE. Lowering ceramides to overcome diabetes. Science. 2019, 365:319-20. 10.1126\/science.aax6594","journal-title":"Science"},{"key":"ref2","unstructured":"IDF Diabetes Atlas | Global Diabetes Data &amp; Statistics. (2021). Accessed. October 26, 2025: https:\/\/diabetesatlas.org."},{"key":"ref3","unstructured":"What is the Diabetes Plate? | American Diabetes Association. (2025). Accessed. October 26, 2025: https:\/\/diabetesfoodhub.org\/blog\/what-diabetes-plate."},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/j.jdiacomp.2020.107734","article-title":"Role of ceramides in the pathogenesis of diabetes mellitus and its complications","volume":"35","author":"Mandal N","year":"2021","unstructured":"Mandal N, Grambergs R, Mondal K, Basu SK, Tahia F, Dagogo-Jack S. Role of ceramides in the pathogenesis of diabetes mellitus and its complications. J Diabetes Complications. 2021, 35:107734. 10.1016\/j.jdiacomp.2020.107734","journal-title":"J Diabetes Complications"},{"key":"ref5","unstructured":"American College of Lifestyle Medicine. Lifestyle Medicine &amp; Food as Medicine Essentials Course Bundle. Chesterfield, MO. American College of Lifestyle Medicine; 2022. Accessed October 26, 2025. https:\/\/lifestylemedicine.org\/project\/essentials\/."},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1111\/dme.13943","article-title":"Ceramides and diabetes mellitus: an update on the potential molecular relationships","volume":"37","author":"Yaribeygi H","year":"2020","unstructured":"Yaribeygi H, Bo S, Ruscica M, Sahebkar A. Ceramides and diabetes mellitus: an update on the potential molecular relationships. Diabet Med. 2020, 37:11-9. 10.1111\/dme.13943","journal-title":"Diabet Med"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1186\/s12933-022-01596-4","article-title":"Circulating ceramides and sphingomyelins and the risk of incident cardiovascular disease among people with diabetes: the strong heart study","volume":"21","author":"Jensen PN","year":"2022","unstructured":"Jensen PN, Fretts AM, Hoofnagle AN, et al.. Circulating ceramides and sphingomyelins and the risk of incident cardiovascular disease among people with diabetes: the strong heart study. Cardiovasc Diabetol. 2022, 21:167. 10.1186\/s12933-022-01596-4","journal-title":"Cardiovasc Diabetol"},{"key":"ref8","unstructured":"Dr. Scott Summers | What is \u2026 ceramides. the new cholesterol? You tube. (2020). Accessed: October 26, 2025: https:\/\/www.youtube.com\/watch?v=JPUwY4DVqY8."},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1155\/2013\/178910","article-title":"Sphingolipid metabolic pathway: an overview of major roles played in human diseases","volume":"2013","author":"Pralhada Rao R","year":"2013","unstructured":"Pralhada Rao R, Vaidyanathan N, Rengasamy M, Mammen Oommen A, Somaiya N, Jagannath MR. Sphingolipid metabolic pathway: an overview of major roles played in human diseases. J Lipids. 2013, 2013:178910. 10.1155\/2013\/178910","journal-title":"J Lipids"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2021.667885","article-title":"Editorial: the role of ceramides in diabetes and cardiovascular disease","volume":"12","author":"Summers SA","year":"2021","unstructured":"Summers SA. Editorial: the role of ceramides in diabetes and cardiovascular disease. Front Endocrinol (Lausanne). 2021, 12:667885. 10.3389\/fendo.2021.667885","journal-title":"Front Endocrinol (Lausanne)"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-nutr-062220-112920","article-title":"The lard works in mysterious ways: ceramides in nutrition-linked chronic disease","volume":"42","author":"Nicholson RJ","year":"2022","unstructured":"Nicholson RJ, Norris MK, Poss AM, Holland WL, Summers SA. The lard works in mysterious ways: ceramides in nutrition-linked chronic disease. Annu Rev Nutr. 2022, 42:115-44. 10.1146\/annurev-nutr-062220-112920","journal-title":"Annu Rev Nutr"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.2337\/db12-0686 \u00a0","article-title":"Ceramides contained in LDL are elevated in type 2 diabetes and promote inflammation and skeletal muscle insulin resistance","volume":"62","author":"Boon J","year":"2013","unstructured":"Boon J, Hoy AJ, Stark R, et al.. Ceramides contained in LDL are elevated in type 2 diabetes and promote inflammation and skeletal muscle insulin resistance. Diabetes. 2013, 62:401-10. 10.2337\/db12-0686 \u00a0","journal-title":"Diabetes"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.2337\/db08-1228","article-title":"Plasma ceramides are elevated in obese subjects with type 2 diabetes and correlate with the severity of insulin resistance","volume":"58","author":"Haus JM","year":"2009","unstructured":"Haus JM, Kashyap SR, Kasumov T, Zhang R, Kelly KR, Defronzo RA, Kirwan JP. Plasma ceramides are elevated in obese subjects with type 2 diabetes and correlate with the severity of insulin resistance. Diabetes. 2009, 58:337-43. 10.2337\/db08-1228","journal-title":"Diabetes"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1038\/ijo.2012.191","article-title":"Plasma sphingolipids are biomarkers of metabolic syndrome in non-human primates maintained on a Western-style diet","volume":"37","author":"Brozinick JT","year":"2013","unstructured":"Brozinick JT, Hawkins E, Hoang Bui H, Kuo MS, Tan B, Kievit P, Grove K. Plasma sphingolipids are biomarkers of metabolic syndrome in non-human primates maintained on a Western-style diet. Int J Obes (Lond). 2013, 37:1064-70. 10.1038\/ijo.2012.191","journal-title":"Int J Obes (Lond)"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1007\/s00125-018-4720-1","article-title":"Relation of plasma ceramides to visceral adiposity, insulin resistance and the development of type 2 diabetes mellitus: the Dallas Heart Study","volume":"61","author":"Neeland IJ","year":"2018","unstructured":"Neeland IJ, Singh S, McGuire DK, et al.. Relation of plasma ceramides to visceral adiposity, insulin resistance and the development of type 2 diabetes mellitus: the Dallas Heart Study. Diabetologia. 2018, 61:2570-9. 10.1007\/s00125-018-4720-1","journal-title":"Diabetologia"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1186\/s12933-024-02505-7","article-title":"Sphingolipid profiling as a biomarker of type 2 diabetes risk: evidence from the MIDUS and PREDIMED studies","volume":"23","author":"Berkowitz L","year":"2024","unstructured":"Berkowitz L, Razquin C, Salazar C, et al.. Sphingolipid profiling as a biomarker of type 2 diabetes risk: evidence from the MIDUS and PREDIMED studies. Cardiovasc Diabetol. 2024, 23:446. 10.1186\/s12933-024-02505-7","journal-title":"Cardiovasc Diabetol"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1007\/s00125-007-0781-2","article-title":"Increased skeletal muscle ceramide level in men at risk of developing type 2 diabetes","volume":"50","author":"Straczkowski M","year":"2007","unstructured":"Straczkowski M, Kowalska I, Baranowski M, et al.. Increased skeletal muscle ceramide level in men at risk of developing type 2 diabetes. Diabetologia. 2007, 50:2366-73. 10.1007\/s00125-007-0781-2","journal-title":"Diabetologia"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1007\/s00125-009-1482-9","article-title":"Link between plasma ceramides, inflammation and insulin resistance: association with serum IL-6 concentration in patients with coronary heart disease","volume":"52","author":"de Mello VD","year":"2009","unstructured":"de Mello VD, Lankinen M, Schwab U, et al.. Link between plasma ceramides, inflammation and insulin resistance: association with serum IL-6 concentration in patients with coronary heart disease. Diabetologia. 2009, 52:2612-5. 10.1007\/s00125-009-1482-9","journal-title":"Diabetologia"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1093\/jn\/nxz259","article-title":"Plasma ceramide species are associated with diabetes risk in participants of the strong heart study","volume":"150","author":"Fretts AM","year":"2020","unstructured":"Fretts AM, Jensen PN, Hoofnagle A, et al.. Plasma ceramide species are associated with diabetes risk in participants of the strong heart study. J Nutr. 2020, 150:1214-22. 10.1093\/jn\/nxz259","journal-title":"J Nutr"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2017.02.019","article-title":"Plasma dihydroceramides are diabetes susceptibility biomarker candidates in mice and humans","volume":"18","author":"Wigger L","year":"2017","unstructured":"Wigger L, Cruciani-Guglielmacci C, Nicolas A, et al.. Plasma dihydroceramides are diabetes susceptibility biomarker candidates in mice and humans. Cell Rep. 2017, 18:2269-79. 10.1016\/j.celrep.2017.02.019","journal-title":"Cell Rep"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1016\/j.jlr.2021.100119","article-title":"Plasma ceramides containing saturated fatty acids are associated with risk of type 2 diabetes","volume":"62","author":"Fretts AM","year":"2021","unstructured":"Fretts AM, Jensen PN, Hoofnagle AN, et al.. Plasma ceramides containing saturated fatty acids are associated with risk of type 2 diabetes. J Lipid Res. 2021, 62:100119. 10.1016\/j.jlr.2021.100119","journal-title":"J Lipid Res"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1007\/s00125-018-4590-6","article-title":"Ceramide stearic to palmitic acid ratio predicts incident diabetes","volume":"61","author":"Hilvo M","year":"2018","unstructured":"Hilvo M, Salonurmi T, Havulinna AS, et al.. Ceramide stearic to palmitic acid ratio predicts incident diabetes. Diabetologia. 2018, 61:1424-34. 10.1007\/s00125-018-4590-6","journal-title":"Diabetologia"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1093\/ajcn\/nqaa114","article-title":"Serum sphingolipids and incident diabetes in a US population with high diabetes burden: the Hispanic Community Health Study\/Study of Latinos (HCHS\/SOL)","volume":"112","author":"Chen GC","year":"2020","unstructured":"Chen GC, Chai JC, Yu B, et al.. Serum sphingolipids and incident diabetes in a US population with high diabetes burden: the Hispanic Community Health Study\/Study of Latinos (HCHS\/SOL). Am J Clin Nutr. 2020, 112:57-65. 10.1093\/ajcn\/nqaa114","journal-title":"Am J Clin Nutr"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1003451","article-title":"Associations among circulating sphingolipids, \u03b2-cell function, and risk of developing type 2 diabetes: a population-based cohort study in China","volume":"17","author":"Yun H","year":"2020","unstructured":"Yun H, Sun L, Wu Q, et al.. Associations among circulating sphingolipids, \u03b2-cell function, and risk of developing type 2 diabetes: a population-based cohort study in China. PLoS Med. 2020, 17:e1003451. 10.1371\/journal.pmed.1003451","journal-title":"PLoS Med"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1016\/j.jdiacomp.2018.12.005","article-title":"Analysis of sphingolipid composition in human vitreous from control and diabetic individuals","volume":"33","author":"Wilmott LA","year":"2019","unstructured":"Wilmott LA, Grambergs RC, Allegood JC, Lyons TJ, Mandal N. Analysis of sphingolipid composition in human vitreous from control and diabetic individuals. J Diabetes Complications. 2019, 33:195-201. 10.1016\/j.jdiacomp.2018.12.005","journal-title":"J Diabetes Complications"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1016\/S0735-1097(22)02530-X","article-title":"The ceramide- and phosphatidylcholine-based Coronary Event Risk Test2 (CERT2) and cardiovascular mortality in men and women with type 2 diabetes","volume":"79","author":"Leiherer A","year":"2022","unstructured":"Leiherer A, Muendlein A, Saely CH, et al.. The ceramide- and phosphatidylcholine-based Coronary Event Risk Test2 (CERT2) and cardiovascular mortality in men and women with type 2 diabetes. J Am Coll Cardiol. 2022, 79:1539. 10.1016\/S0735-1097(22)02530-X","journal-title":"J Am Coll Cardiol"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1016\/S0735-1097(24)04016-6","article-title":"Ceramides predict the development of type 2 diabetes","volume":"83","author":"Leiherer A","year":"2024","unstructured":"Leiherer A, Muendlein A, Plattner T, et al.. Ceramides predict the development of type 2 diabetes. J Am Coll Cardiol. 2024, 83:10.1016\/S0735-1097(24)04016-6","journal-title":"J Am Coll Cardiol"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabres.2021.108991","article-title":"Association of plasma ceramides with prevalent and incident type 2 diabetes mellitus in middle and older aged adults","volume":"179","author":"Dugani SB","year":"2021","unstructured":"Dugani SB, Christenson LR, Aakre JA, Bui HH, Vella A, Mielke MM. Association of plasma ceramides with prevalent and incident type 2 diabetes mellitus in middle and older aged adults. Diabetes Res Clin Pract. 2021, 179:108991. 10.1016\/j.diabres.2021.108991","journal-title":"Diabetes Res Clin Pract"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1515\/jpem-2012-0407","article-title":"Plasma ceramides are elevated in female children and adolescents with type 2 diabetes","volume":"26","author":"Lopez X","year":"2013","unstructured":"Lopez X, Goldfine AB, Holland WL, Gordillo R, Scherer PE. Plasma ceramides are elevated in female children and adolescents with type 2 diabetes. J Pediatr Endocrinol Metab. 2013, 26:995-8. 10.1515\/jpem-2012-0407","journal-title":"J Pediatr Endocrinol Metab"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.2337\/diabetes.51.5.1437","article-title":"Prolonged exposure to free fatty acids has cytostatic and pro-apoptotic effects on human pancreatic islets: evidence that beta-cell death is caspase mediated, partially dependent on ceramide pathway, and Bcl-2 regulated","volume":"51","author":"Lupi R","year":"2002","unstructured":"Lupi R, Dotta F, Marselli L, et al.. Prolonged exposure to free fatty acids has cytostatic and pro-apoptotic effects on human pancreatic islets: evidence that beta-cell death is caspase mediated, partially dependent on ceramide pathway, and Bcl-2 regulated. Diabetes. 2002, 51:1437-42. 10.2337\/diabetes.51.5.1437","journal-title":"Diabetes"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.2337\/dc18-0071","article-title":"Saturated fat is more metabolically harmful for the human liver than unsaturated fat or simple sugars","volume":"41","author":"Luukkonen PK","year":"2018","unstructured":"Luukkonen PK, S\u00e4devirta S, Zhou Y, et al.. Saturated fat is more metabolically harmful for the human liver than unsaturated fat or simple sugars. Diabetes Care. 2018, 41:1732-9. 10.2337\/dc18-0071","journal-title":"Diabetes Care"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1002\/oby.21980","article-title":"Intramyocellular lipid droplet size rather than total lipid content is related to insulin sensitivity after 8 weeks of overfeeding","volume":"25","author":"Covington JD","year":"2017","unstructured":"Covington JD, Johannsen DL, Coen PM, et al.. Intramyocellular lipid droplet size rather than total lipid content is related to insulin sensitivity after 8 weeks of overfeeding. Obesity (Silver Spring). 2017, 25:2079-87. 10.1002\/oby.21980","journal-title":"Obesity (Silver Spring)"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.1002\/oby.20508","article-title":"The effect of short-term overfeeding on serum lipids in healthy humans","volume":"21","author":"Heilbronn LK","year":"2013","unstructured":"Heilbronn LK, Coster AC, Campbell LV, et al.. The effect of short-term overfeeding on serum lipids in healthy humans. Obesity (Silver Spring). 2013, 21:E649-59. 10.1002\/oby.20508","journal-title":"Obesity (Silver Spring)"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.1093\/jn\/nxaa269","article-title":"Dietary patterns, ceramide ratios, and risk of all-cause and cause-specific mortality: the Framingham Offspring Study","volume":"150","author":"Walker ME","year":"2020","unstructured":"Walker ME, Xanthakis V, Peterson LR, et al.. Dietary patterns, ceramide ratios, and risk of all-cause and cause-specific mortality: the Framingham Offspring Study. J Nutr. 2020, 150:2994-3004. 10.1093\/jn\/nxaa269","journal-title":"J Nutr"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.1093\/jn\/nxz048","article-title":"Identification of Plasma Lipid Metabolites Associated with Nut Consumption in US Men and Women","volume":"149","author":"Malik VS","year":"2019","unstructured":"Malik VS, Guasch-Ferre M, Hu FB, et al.. Identification of Plasma Lipid Metabolites Associated with Nut Consumption in US Men and Women. J Nutr. 2019, 149:1215-21. 10.1093\/jn\/nxz048","journal-title":"J Nutr"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.1093\/ajcn\/nqz257","article-title":"Cumulative sugar-sweetened beverage consumption is associated with higher concentrations of circulating ceramides in the Framingham Offspring Cohort","volume":"111","author":"Walker ME","year":"2020","unstructured":"Walker ME, Xanthakis V, Moore LL, Vasan RS, Jacques PF. Cumulative sugar-sweetened beverage consumption is associated with higher concentrations of circulating ceramides in the Framingham Offspring Cohort. Am J Clin Nutr. 2020, 111:420-8. 10.1093\/ajcn\/nqz257","journal-title":"Am J Clin Nutr"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0300844","article-title":"Mediterranean diet effects on vascular health and serum levels of adipokines and ceramides","volume":"19","author":"Daidone M","year":"2024","unstructured":"Daidone M, Casuccio A, Puleo MG, et al.. Mediterranean diet effects on vascular health and serum levels of adipokines and ceramides. PLoS One. 2024, 19:e0300844. 10.1371\/journal.pone.0300844","journal-title":"PLoS One"},{"key":"ref38","doi-asserted-by":"publisher","DOI":"10.3390\/metabo11090632","article-title":"A randomized controlled dietary intervention improved the serum lipid signature towards a less atherogenic profile in patients with rheumatoid arthritis","volume":"11","author":"Lindqvist HM","year":"2021","unstructured":"Lindqvist HM, B\u00e4rebring L, Gjertsson I, Jylh\u00e4 A, Laaksonen R, Winkvist A, Hilvo M. A randomized controlled dietary intervention improved the serum lipid signature towards a less atherogenic profile in patients with rheumatoid arthritis. Metabolites. 2021, 11:10.3390\/metabo11090632","journal-title":"Metabolites"},{"key":"ref39","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.116.024261","article-title":"Plasma ceramides, Mediterranean diet, and incident cardiovascular disease in the PREDIMED trial (Prevenci\u00f3n con dieta Mediterr\u00e1nea)","volume":"135","author":"Wang DD","year":"2017","unstructured":"Wang DD, Toledo E, Hruby A, et al.. Plasma ceramides, Mediterranean diet, and incident cardiovascular disease in the PREDIMED trial (Prevenci\u00f3n con dieta Mediterr\u00e1nea). Circulation. 2017, 135:2028-40. 10.1161\/CIRCULATIONAHA.116.024261","journal-title":"Circulation"},{"key":"ref40","doi-asserted-by":"publisher","DOI":"10.14814\/phy2.13329","article-title":"Efficacy of nutritional interventions to lower circulating ceramides in young adults: FRUVEDomic pilot study","volume":"5","author":"Mathews AT","year":"2017","unstructured":"Mathews AT, Famodu OA, Olfert MD, et al.. Efficacy of nutritional interventions to lower circulating ceramides in young adults: FRUVEDomic pilot study. Physiol Rep. 2017, 5:10.14814\/phy2.13329","journal-title":"Physiol Rep"},{"key":"ref41","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0022646","article-title":"Whole grain products, fish and bilberries alter glucose and lipid metabolism in a randomized, controlled trial: the Sysdimet study","volume":"6","author":"Lankinen M","year":"2011","unstructured":"Lankinen M, Schwab U, Kolehmainen M, et al.. Whole grain products, fish and bilberries alter glucose and lipid metabolism in a randomized, controlled trial: the Sysdimet study. PLoS One. 2011, 6:e22646. 10.1371\/journal.pone.0022646","journal-title":"PLoS One"},{"key":"ref42","doi-asserted-by":"publisher","DOI":"10.3390\/jcm8040527","article-title":"Associations of adiposity and diet quality with serum ceramides in middle-aged adults with cardiovascular risk factors","volume":"8","author":"Drazba MA","year":"2019","unstructured":"Drazba MA, Hol\u00e1skov\u00e1 I, Sahyoun NR, Ventura Marra M. Associations of adiposity and diet quality with serum ceramides in middle-aged adults with cardiovascular risk factors. J Clin Med. 2019, 8:10.3390\/jcm8040527","journal-title":"J Clin Med"},{"key":"ref43","doi-asserted-by":"publisher","DOI":"10.3945\/jn.115.220459","article-title":"A healthy Nordic diet alters the plasma lipidomic profile in adults with features of metabolic syndrome in a multicenter randomized dietary intervention","volume":"146","author":"Lankinen M","year":"2015","unstructured":"Lankinen M, Schwab U, Kolehmainen M, et al.. A healthy Nordic diet alters the plasma lipidomic profile in adults with features of metabolic syndrome in a multicenter randomized dietary intervention. J Nutr. 2015, 146:662-72. 10.3945\/jn.115.220459","journal-title":"J Nutr"},{"key":"ref44","doi-asserted-by":"publisher","DOI":"10.3390\/nu12113586","article-title":"Effects of a lacto-ovo-vegetarian diet on the plasma lipidome and its association with atherosclerotic burden in patients with coronary artery disease-a randomized, open-label, cross-over study","volume":"12","author":"Djekic D","year":"2020","unstructured":"Djekic D, Shi L, Calais F, Carlsson F, Landberg R, Hy\u00f6tyl\u00e4inen T, Fr\u00f8bert O. Effects of a lacto-ovo-vegetarian diet on the plasma lipidome and its association with atherosclerotic burden in patients with coronary artery disease-a randomized, open-label, cross-over study. Nutrients. 2020, 12:10.3390\/nu12113586","journal-title":"Nutrients"},{"key":"ref45","doi-asserted-by":"publisher","DOI":"10.1111\/dom.13773","article-title":"Mechanisms underlying the cardiometabolic protective effect of walnut consumption in obese people: a cross-over, randomized, double-blind, controlled inpatient physiology study","volume":"21","author":"Tuccinardi D","year":"2019","unstructured":"Tuccinardi D, Farr OM, Upadhyay J, et al.. Mechanisms underlying the cardiometabolic protective effect of walnut consumption in obese people: a cross-over, randomized, double-blind, controlled inpatient physiology study. Diabetes Obes Metab. 2019, 21:2086-95. 10.1111\/dom.13773","journal-title":"Diabetes Obes Metab"},{"key":"ref46","doi-asserted-by":"publisher","DOI":"10.1002\/dmrr.3492","article-title":"An extra virgin olive oil-enriched chocolate spread positively modulates insulin-resistance markers compared with a palm oil-enriched one in healthy young adults: A double-blind, cross-over, randomised controlled trial","volume":"38","author":"Tuccinardi D","year":"2022","unstructured":"Tuccinardi D, Di Mauro A, Lattanzi G, et al.. An extra virgin olive oil-enriched chocolate spread positively modulates insulin-resistance markers compared with a palm oil-enriched one in healthy young adults: A double-blind, cross-over, randomised controlled trial. Diabetes Metab Res Rev. 2022, 38:e3492. 10.1002\/dmrr.3492","journal-title":"Diabetes Metab Res Rev"},{"key":"ref47","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2019-00160","article-title":"Overeating saturated fat promotes fatty liver and ceramides compared with polyunsaturated fat: a randomized trial","volume":"104","author":"Rosqvist F","year":"2019","unstructured":"Rosqvist F, Kullberg J, St\u00e5hlman M, et al.. Overeating saturated fat promotes fatty liver and ceramides compared with polyunsaturated fat: a randomized trial. J Clin Endocrinol Metab. 2019, 104:6207-19. 10.1210\/jc.2019-00160","journal-title":"J Clin Endocrinol Metab"},{"key":"ref48","doi-asserted-by":"publisher","DOI":"10.2337\/db12-0363","article-title":"A lipidomics analysis of the relationship between dietary fatty acid composition and insulin sensitivity in young adults","volume":"62","author":"Kien CL","year":"2013","unstructured":"Kien CL, Bunn JY, Poynter ME, et al.. A lipidomics analysis of the relationship between dietary fatty acid composition and insulin sensitivity in young adults. Diabetes. 2013, 62:1054-63. 10.2337\/db12-0363","journal-title":"Diabetes"},{"key":"ref49","doi-asserted-by":"publisher","DOI":"10.3390\/metabo11020093","article-title":"Dietary fat and protein intake in relation to plasma sphingolipids as determined by a large-scale lipidomic analysis","volume":"11","author":"Seah JY","year":"2021","unstructured":"Seah JY, Chew WS, Torta F, et al.. Dietary fat and protein intake in relation to plasma sphingolipids as determined by a large-scale lipidomic analysis. Metabolites. 2021, 11:10.3390\/metabo11020093","journal-title":"Metabolites"},{"key":"ref50","doi-asserted-by":"publisher","DOI":"10.3945\/jn.115.210104","article-title":"Postprandial plasma phospholipids in men are influenced by the source of dietary fat","volume":"145","author":"Meikle PJ","year":"2015","unstructured":"Meikle PJ, Barlow CK, Mellett NA, et al.. Postprandial plasma phospholipids in men are influenced by the source of dietary fat. J Nutr. 2015, 145:2012-8. 10.3945\/jn.115.210104","journal-title":"J Nutr"},{"key":"ref51","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabet.2019.06.002","article-title":"Dairy consumption is associated with lower plasma dihydroceramides in women from the D.E.S.I.R. cohort","volume":"46","author":"Fumeron F","year":"2020","unstructured":"Fumeron F, Nicolas A, Bastard JP, et al.. Dairy consumption is associated with lower plasma dihydroceramides in women from the D.E.S.I.R. cohort. Diabetes Metab. 2020, 46:144-9. 10.1016\/j.diabet.2019.06.002","journal-title":"Diabetes Metab"},{"key":"ref52","doi-asserted-by":"publisher","DOI":"10.1007\/s00421-011-2041-x","article-title":"Muscle ceramide content is similar after 3 weeks' consumption of fat or carbohydrate diet in a crossover design in patients with type 2 diabetes","volume":"112","author":"Helge JW","year":"2012","unstructured":"Helge JW, Tobin L, Drachmann T, Hellgren LI, Dela F, Galbo H. Muscle ceramide content is similar after 3 weeks' consumption of fat or carbohydrate diet in a crossover design in patients with type 2 diabetes. Eur J Appl Physiol. 2012, 112:911-8. 10.1007\/s00421-011-2041-x","journal-title":"Eur J Appl Physiol"},{"key":"ref53","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0005258","article-title":"Fatty fish intake decreases lipids related to inflammation and insulin signaling--a lipidomics approach","volume":"4","author":"Lankinen M","year":"2009","unstructured":"Lankinen M, Schwab U, Erkkil\u00e4 A, et al.. Fatty fish intake decreases lipids related to inflammation and insulin signaling--a lipidomics approach. PLoS One. 2009, 4:e5258. 10.1371\/journal.pone.0005258","journal-title":"PLoS One"},{"key":"ref54","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0042550","article-title":"Fish oil supplementation alters the plasma lipidomic profile and increases long-chain PUFAs of phospholipids and triglycerides in healthy subjects","volume":"7","author":"Ottestad I","year":"2012","unstructured":"Ottestad I, Hassani S, Borge GI, et al.. Fish oil supplementation alters the plasma lipidomic profile and increases long-chain PUFAs of phospholipids and triglycerides in healthy subjects. PLoS One. 2012, 7:e42550. 10.1371\/journal.pone.0042550","journal-title":"PLoS One"},{"key":"ref55","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2022.112955","article-title":"Berberine reduces hepatic ceramide levels to improve insulin resistance in HFD-fed mice by inhibiting HIF-2\u03b1","volume":"150","author":"Xia QS","year":"2022","unstructured":"Xia QS, Wu F, Wu WB, et al.. Berberine reduces hepatic ceramide levels to improve insulin resistance in HFD-fed mice by inhibiting HIF-2\u03b1. Biomed Pharmacother. 2022, 150:112955. 10.1016\/j.biopha.2022.112955","journal-title":"Biomed Pharmacother"},{"key":"ref56","doi-asserted-by":"publisher","DOI":"10.1194\/jlr.RA119000346","article-title":"Dietary inulin decreases circulating ceramides by suppressing neutral sphingomyelinase expression and activity in mice","volume":"61","author":"Deng P","year":"2020","unstructured":"Deng P, Hoffman JB, Petriello MC, et al.. Dietary inulin decreases circulating ceramides by suppressing neutral sphingomyelinase expression and activity in mice. J Lipid Res. 2020, 61:45-53. 10.1194\/jlr.RA119000346","journal-title":"J Lipid Res"},{"key":"ref57","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2019.00577","article-title":"The role of ceramides in insulin resistance","volume":"10","author":"Sokolowska E","year":"2019","unstructured":"Sokolowska E, Blachnio-Zabielska A. The role of ceramides in insulin resistance. Front Endocrinol (Lausanne). 2019, 10:577. 10.3389\/fendo.2019.00577","journal-title":"Front Endocrinol (Lausanne)"},{"key":"ref58","doi-asserted-by":"publisher","DOI":"10.1186\/s12937-017-0271-4","article-title":"A healthy approach to dietary fats: understanding the science and taking action to reduce consumer confusion","volume":"16","author":"Liu AG","year":"2017","unstructured":"Liu AG, Ford NA, Hu FB, Zelman KM, Mozaffarian D, Kris-Etherton PM. A healthy approach to dietary fats: understanding the science and taking action to reduce consumer confusion. Nutr J. 2017, 16:53. 10.1186\/s12937-017-0271-4","journal-title":"Nutr J"},{"key":"ref59","unstructured":"How many calories should you eat in a day? | Atlantic Health. (2023). Accessed. November 18, 2025: https:\/\/ahs.atlantichealth.org\/about-us\/stay-connected\/news\/content-central\/2023\/how-many-calories.html."},{"key":"ref60","article-title":"Nutrition Therapy & Pathophysiology, Fourth Edition","author":"Nelms M","year":"2020","unstructured":"Nelms M, Sucher KP, Long S. Nutrition Therapy &amp; Pathophysiology, Fourth Edition. Cengage Learning, Inc., Boston; 2020."}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/484624-ceramides-and-type-2-diabetes-a-scoping-review-of-mechanisms-insulin-resistance-and-nutritional-interventions","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T17:05:17Z","timestamp":1778519117000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/484624-ceramides-and-type-2-diabetes-a-scoping-review-of-mechanisms-insulin-resistance-and-nutritional-interventions"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,11]]},"references-count":60,"URL":"https:\/\/doi.org\/10.7759\/cureus.108667","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5,11]]}}}